BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United...

index on July 24 due to its acqusition by AT&T, and replaced by BioMarin Pharmaceutical on July 27. Sigma-Aldrich was removed on July 31, after being acquired...

digestive system if taken by mouth. Vosoritide was developed by BioMarin Pharmaceutical and got orphan drug status in the US as well as the European Union...

therapy used for the treatment of hemophilia A. It was developed by BioMarin Pharmaceutical. Valoctocogene roxaparvovec is made of a virus (AAV5) that has...

(1978– ) BioCryst (1986– ) Bioderma (1977– ) Bio Farma (1890– ) Biogen (1978– ) Bioinvent (1983– ) BioLineRx (2003– ) BioMarin (1997– ) bioMérieux (1963–...

investigational drugs on behalf of terminally ill patients. In 2013, BioMarin Pharmaceutical was at the center of a high-profile debate regarding expanded access...

with Kuvan is US$100,000 per year. BioMarin holds the patent for Kuvan until at least 2024, but Par Pharmaceutical has a right to produce a generic version...

which was developed through a series of companies ending with BioMarin Pharmaceutical which obtained European approval in 2009 under the trade name Firdapse...

synthetic version of this enzyme. Elosulfase alfa was developed by BioMarin Pharmaceutical Inc. and approved for use in the US by the Food and Drug Administration...

Aging, and several biotech firms, such as Biosearch Technologies, BioMarin Pharmaceutical and Ultragenyx. Several small technology companies are also based...